Articles Mentioning Biotechnology Stocks

Results 1 - 10 of 389 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Biotechnology

Investing | February 21, 2015

Pssst... Pfizer Just Told Investors That This is the Next Big Thing

Pfizer Inc.'s acquisition of Hospira could signal that investors should embrace biosimilar drugmakers.

Investing | February 20, 2015

$20 Billion Market: What’s the Best Stock to Buy?

Three drug companies to watch as biologics come off patent and investors anticipate a biosimilar boom -- here's what you need to know.

Investing | February 18, 2015

Is Gilead Sciences Inc. Stock Cheap Now?

Gilead Sciences has fallen by double-digits from its 52-week high. Is the stock now too cheap to ignore?

Investing | February 16, 2015

Deal-Hungry Pfizer Won't Stop With Hospira; Who Could Be Next?

Pfizer recently acquired Hospira for $17 billion, but it has plenty of fuel left to go after more deals to boost its pipeline and shareholder value.

Investing | February 15, 2015

The Small-Cap Biotech Stock You Should Be Watching

Motley Fool experts offer up insight into three intriguing small-cap biotech stocks.

Investing | February 14, 2015

2 Small Biotech Stocks Dreaming Big in Hepatitis C

Exciting but speculative -- Industry Focus examines two companies making strides in the treatment of hepatitis C.

Investing | February 12, 2015

Forget Gilead Sciences: Here Are 3 Better Biotech Stocks

Biogen Idec, Regeneron, and Amgen Inc. may be better bets than Gilead Sciences.

Investing | February 10, 2015

Will Pfizer Inc. Break Up in 2015?

Pfizer's management has been slowly steering the company toward a game-changing split. Will this much anticipated event finally take place in 2015?

Investing | February 04, 2015

Why Achillion Pharmaceuticals, Inc. Stock Is Crashing Today

Shares of this clinical-stage biotech are crashing today. Here's why.

Investing | February 01, 2015

This Could Be Game-Changing News in the Battle Against Multiple Sclerosis

Multiple sclerosis affects more than 400,000 people in the United States and around 2.5 million people globally. That's why this potentially game-changing study's results are so promising and important.

Results 1 - 10 of 389 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Biotechnology